文献速递生殖医学

人卵巢小窦卵泡卵泡液蛋白质组揭示卵泡发生与卵母细胞成熟线索

Proteome of fluid from human ovarian small antral follicles reveals insights in folliculogenesis and oocyte maturation.
PubMed 文献 · Hum Reprod · 2021-01-01

研究用质谱分析31名约28.5岁女性未刺激卵巢小窦卵泡(6.1±0.4 mm)卵泡液,共鉴定2461种蛋白,其中1108种首次在卵泡液报道;比较13个含卵母细胞卵泡液发现,能成熟至MII的卵泡液有35种蛋白下调和65种上调,提示蛋白变化早于卵母细胞成熟。

要点

  • 小窦卵泡液可鉴定2461种蛋白,1108种为首次报道。
  • 24种蛋白与卵泡调节过程相关。
  • 能成熟卵母细胞的卵泡液有35种蛋白下调和65种上调。

核心结论

  • 小窦卵泡液质谱分析可鉴定更多蛋白,且蛋白水平变化与后续卵母细胞成熟能力相关。

研究设计与样本

  • 研究收集31名约28.5岁因生育力保存行单侧卵巢切除术女性的未刺激小窦卵泡(6.1±0.4 mm)卵泡液,用质谱结合高通量、靶向蛋白质组学和生物信息学分析。
  • 另分析13个含卵母细胞的卵泡液,比较IVM中能或不能成熟至第二次减数分裂中期(MII)的卵母细胞对应卵泡液蛋白谱。

主要发现

  • 共鉴定2461种蛋白,其中1108种首次在卵泡液中发现。
  • 24种鉴定蛋白与卵泡调节过程相关。
  • 能成熟至MII的卵母细胞周围小窦卵泡液中,35种蛋白下调、65种蛋白上调。

临床怎么用

  • 小窦卵泡液蛋白质组可反映卵泡发育早期微环境,为评估卵母细胞成熟潜能提供候选蛋白标志。
  • 若进一步研究证实,或可开辟在排卵前卵泡中增强或减弱卵母细胞活力的新途径。

局限性

  • 取样卵泡中处于闭锁状态的比例不确定。
  • 虽小心抽吸和处理以去除污染物,仍不能确保无技术原因所致细胞裂解来源蛋白。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is it possible to identify by mass spectrometry a wider range of proteins and key proteins involved in folliculogenesis and oocyte growth and development by studying follicular fluid (FF) from human small antral follicles (hSAF)? SUMMARY ANSWER: The largest number of proteins currently reported in human FF was identified in this study analysing hSAF where several proteins showed a strong relationship with follicular developmental processes. WHAT IS KNOWN ALREADY: Protein composition of human ovarian FF constitutes the microenvironment for oocyte development. Previous proteomics studies have analysed fluids from pre-ovulatory follicles, where large numbers of plasma constituents are transferred through the follicular basal membrane. This attenuates the detection of low abundant proteins, however, the basal membrane of small antral follicles is less permeable, making it possible to detect a large number of proteins, and thereby offering further insights in folliculogenesis. STUDY DESIGN, SIZE, DURATION: Proteins in FF from unstimulated hSAF (size 6.1 ± 0.4 mm) were characterised by mass spectrometry, supported by high-throughput and targeted proteomics and bioinformatics. The FF protein profiles from hSAF containing oocytes, capable or not of maturing to metaphase II of the second meiotic division during an IVM (n = 13, from 6 women), were also analysed. PARTICIPANTS/MATERIALS, SETTING, METHODS: We collected FF from hSAF of ovaries that had been surgically removed from 31 women (∼28.5 years old) undergoing unilateral ovariectomy for fertility preservation. MAIN RESULTS AND THE ROLE OF CHANCE: In total, 2461 proteins were identified, of which 1108 identified for the first time in FF. Of the identified proteins, 24 were related to follicular regulatory processes. A total of 35 and 65 proteins were down- and up-regulated, respectively, in fluid from hSAF surrounding oocytes capable of maturing (to MII). We found that changes at the protein level occur already in FF from small antral follicles related to subsequent oocyte maturation. LIMITATIONS, REASONS FOR CAUTION: A possible limitation of our study is the uncertainty of the proportion of the sampled follicles that are undergoing atresia. Although the FF samples were carefully aspirated and processed to remove possible contaminants, we cannot ensure the absence of some proteins derived from cellular lysis provoked by technical reasons. WIDER IMPLICATIONS OF THE FINDINGS: This study is, to our knowledge, the first proteomics characterisation of FF from hSAF obtained from women in their natural menstrual cycle. We demonstrated that the analysis by mass spectrometry of FF from hSAF allows the identification of a greater number of proteins compared to the results obtained from previous analyses of larger follicles. Significant differences found at the protein level in hSAF fluid could predict the ability of the enclosed oocyte to sustain meiotic resumption. If this can be confirmed in further studies, it demonstrates that the viability of the oocyte is determined early on in follicular development and this may open up new pathways for augmenting or attenuating subsequent oocyte viability in the pre-ovulatory follicle ready to undergo ovulation. STUDY FUNDING/COMPETING INTEREST(S): The authors thank the financial support from ReproUnion, which is funded by the Interreg V EU programme. No conflict of interest was reported by the authors. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Pla I, Sanchez A, Pors SE, et al. Proteome of fluid from human ovarian small antral follicles reveals insights in folliculogenesis and oocyte maturation. Hum Reprod. 2021. PMID: 33313811. doi:10.1093/humrep/deaa335

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。